View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
August 17, 2022

Medical Devices industry cross border deals total $2.6bn globally in July 2022

By Carmen

Total Medical devices industry cross border deals worth $2.6bn were announced globally for July 2022, with the $1.54bn private equity deal with Meridian Bioscience being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 17.8% over the previous month of $3.14bn and a drop of 28.3% when compared with the last 12-month average of $3.6bn.

In terms of number of cross border deals, the sector saw a drop of 18.64% with 48 deals in July 2022 when compared to the last 12-month average of 59 deals.

In value terms, North America led the activity with cross border deals worth $2.23bn in July 2022.

Medical devices industry cross border deals in July 2022: Top deals

The top five cross border deals accounted for 82.2% of the overall value during July 2022.

The combined value of the top five cross border deals stood at $2.12bn, against the overall value of $2.6bn recorded for the month.

The top five Medical devices industry cross border deals of July 2022 tracked by GlobalData were:

1) SD Biosensor and SJL Partners $1.54bn private equity deal with Meridian Bioscience

2) The $223m venture financing of Cleerly by Breyer Capital,Cigna Ventures,DigiTx Partners,Fidelity Management & Research,Heartland Healthcare Capital,LRVHealth,Mirae Asset Capital,New Leaf Ventures,Novartis,Peter Thiel,Piper Sandler Merchant Banking,Sands Capital Management,T Rowe Price Associates,T. Rowe Price Investment Management and Vensana Capital

3) Peninsula Capital Partners $143.03m private equity deal with Red Kiwi

4) The $110m venture financing of Orchestra BioMed by Medtronic,Perceptive Advisors,RTW Investments,SternAegis Ventures and Terumo

5) Emerson Collective (Emmerson Collective) and KIRKBI Invest $100m venture financing deal with Kerecis ehf

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network